- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Lyell Immunopharma laps up $425m in IPO
The GlaxoSmithKline and Celgene-backed immunotherapy developer has floated in the middle of its range on the Nasdaq Global Market.
Jun 18, 2021Neo4J nets $325m in series F round
Alphabet unit GV and the Deutsche Telekom-backed DTCP both invested in the graph database software provider at a valuation topping $2bn.
Jun 18, 2021Wise applies for direct listing
The Mitsui-backed money transfer service formerly known as TransferWise was valued at $5bn in a secondary share sale almost a year ago.
Jun 18, 2021KeepTruckin hauls in $190m
The GV-backed fleet management technology provider has increased its total funding to $417m in a series E round valuing it at $2bn.
Jun 18, 2021Vision Fund helps Vianai find $140m
SoftBank Vision Fund 2 led artificial intelligence technology developer Vianai Systems' series A round, participating alongside a range of private investors.
Jun 18, 2021Oxford Instruments wins over WITec
University of Ulm spinout WITec has agreed to a $50m acquisition by Oxford Instruments, itself the first-ever spinout of University of Oxford.
Jun 18, 2021UChicago appoints duo to Duality
Chuck Vallurupalli and Preeti Chalsani will serve as senior director and deputy director, respectively, of the quantum accelerator.
Jun 18, 2021Circle Pharma draws $66m series C
The oncology therapeutics developer has added $66m to its coffers thanks to investors including Berkeley Catalyst Fund.
Jun 18, 2021Flagship charges ahead with $3.37bn
Flagship Pioneering has re-opened its Fund VII to raise an additional $2.23bn that brought the vehicle’s total capital to $3.37bn.
Jun 18, 2021IBioIC looks to drive spinout generation
The Industrial Biotechnology Innovation Centre will invest in research projects at Scottish universities to support the creation of more spinouts.
Jun 18, 2021Mnemo Therapeutics redeems $91m
Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.
Jun 18, 2021Beamery gets $138m boost
Accenture Ventures, M12 and Workday Ventures all contributed to a series C round reportedly valuing the recruitment and retention technology provider at $800m.
Jun 18, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


